News Search

Tag: Car-T

Penn spinout Verismo Therapeutics Makes Agreement to Fund University Research of KIR-CAR platform of Car-T to Target Solid Tumors

Learn about Penn spinout Verismo Therapeutics' agreement to fund four years of university research of KIR-CAR platform of Car-T to target solid tumors.

Car-T Pioneer Bruce Levine Speaks on the Past, Present and Future of Cancer Therapy

Learn about Dr. Bruce Levine's predictions for the future uses of Car-T therapy.

Gnubiotics and Penn to Explore Car-T Therapy in Combination with Glycopeptides to Target Solid Tumors

This collaboration will take place through company-sponsored pre-clinical research studies in the laboratory of Avery Posey, PhD, an assistant professor at the Perelman School of Medicine.

Five Years of Data Show Long-term Promise for Penn and Novartis’ Car-T Pioneer Kymriah

Five years after Penn and Novartis made history with the FDA approval of Kymriah, a recent study shows the long-term impact of the medication on patient remission rates. 

Filter

Skip to content